You Searched For "COVAXIN"

Hyderabad-based Bharat Biotech to conduct clinical trial of `Covaxin on kids
Hyderabad-based Bharat Biotech to conduct clinical trial of `Covaxin' on kids

Drugs Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee (SEC) and accorded permission to conduct the...

By Newsmeter Network  Published on 13 May 2021 5:41 AM GMT


Hyd based Bharat Biotech reduces price of Covaxin from Rs 600 to Rs 400 for states
Hyd based Bharat Biotech reduces price of Covaxin from Rs 600 to Rs 400 for states

On April 24, Bharat Biotech announced that its COVID19 vaccine Covaxin will be sold at Rs 600 a shot to states and Rs 1200 to private hospitals

By Newsmeter Network  Published on 29 April 2021 12:42 PM GMT


Covaxin priced at Rs 600 for States, Rs 1200 for private hospitals
Covaxin priced at Rs 600 for States, Rs 1200 for private hospitals

On April 21 Serum Institute of India announced that its COVID19 vaccine Covishield will be sold at Rs 400 a shot to states and Rs 600 to private...

By Newsmeter Network  Published on 25 April 2021 3:32 AM GMT


Bharat Biotechs Covaxin interim phase 3 trials show 78% efficacy against COVID-19
Bharat Biotech's Covaxin interim phase 3 trials show 78% efficacy against COVID-19

Phase 3 interim analysis results of Covaxin and said it had an efficacy of 78 per cent against mild, moderate, and severe COVID-19 cases.

By Newsmeter Network  Published on 21 April 2021 4:06 PM GMT


Covaxin neutralizes double mutant strain of COVID-19: ICMR study
Covaxin neutralizes double mutant strain of COVID-19: ICMR study

ICMR-NIV has recently been successful in isolating and culturing the double mutant strain B.1.617 SARS-COV-2 identified in certain regions of India...

By Newsmeter Network  Published on 21 April 2021 11:04 AM GMT


Hyd based Bharat Biotech to produce 700 million doses of Covaxin annually
Hyd based Bharat Biotech to produce 700 million doses of Covaxin annually

Manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore, the company said.

By Newsmeter Network  Published on 20 April 2021 10:51 AM GMT


Centre ramps up Covaxin production, ropes in Hyd-based Indian Immunologicals Ltd. to produce vaccine
Centre ramps up Covaxin production, ropes in Hyd-based Indian Immunologicals Ltd. to produce vaccine

Centre ramps up Covaxin production, to produce 10 crore doses per month by September

By Newsmeter Network  Published on 16 April 2021 1:23 PM GMT


Interval of Covishield first and second dose revised to 6-8 weeks
Interval of Covishield first and second dose revised to 6-8 weeks

The recommendation has been revised to provide the second dose of Covishield 6-8 weeks after the 1st dose, instead of the earlier interval of 4-6...

By Newsmeter Network  Published on 22 March 2021 10:25 AM GMT


CDSCO drops clinical trial mode for Covaxin easing restrictions for its use
CDSCO drops 'clinical trial mode' for Covaxin easing restrictions for its use

The Central Drugs Standard Control Organisation (CDSCO) on 11 March changed the status of Bharat Biotech’s COVID-19 vaccine Covaxin and dropped the...

By Newsmeter Network  Published on 11 March 2021 2:52 PM GMT


Timeline: How Hyderabad-based Bharat Biotech developed effective vaccine against coronavirus
Timeline: How Hyderabad-based Bharat Biotech developed effective vaccine against coronavirus

Covaxin has shown an interim vaccine efficacy of 81% in preventing Covid-19.

By Newsmeter Network  Published on 4 March 2021 5:13 AM GMT


Hyd based Bharat Biotechs COVID19 vaccine Covaxin shows 81% efficacy
Hyd based Bharat Biotech's COVID19 vaccine Covaxin shows 81% efficacy

Bharat Biotech on March 3 announced the Phase 3 clinical trial results for its COVID19 vaccine candidate Covaxin.

By Newsmeter Network  Published on 3 March 2021 11:56 AM GMT


Wearing poll-bound Assams gamchha, PM Modi takes Bharat Biotechs `Covaxin jab at Delhis AIIMS
Wearing poll-bound Assam's 'gamchha', PM Modi takes Bharat Biotech's `Covaxin' jab at Delhi's AIIMS

Prime Minister Narendra Modi on Monday received the first dose of Covaxin, the indigenous Coronavirus vaccine developed by Bharat Biotech,

By Newsmeter Network  Published on 1 March 2021 3:28 AM GMT


Share it